---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-057836"
form_type: "8-K"
ticker: "MRKR"
cik: "0001094038"
company_name: "Marker Therapeutics, Inc."
filed_at: "2025-06-09T23:59:59+00:00"
generated_at: "2026-05-19T16:44:03.470472+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Marker Therapeutics stockholders elect directors, approve say-on-pay, ratify auditor at 2025 annual meeting

## Summary
- Four director nominees elected: Eansor (4.1M for), Elms (4.1M), Knobil (4.1M), Vera (4.1M); broker non-votes 2.8M.
- Advisory vote on named executive officer compensation passed: 4.45M for, 343K against, 13.9K abstain.
- Ratification of Marcum LLP as independent auditor for FY2025: 7.49M for, 80.8K against, 53.9K abstain.
- Total shares outstanding 11.3M; 67.43% quorum (7.63M shares present or proxy).

## SEC filing metadata
- accession: 0001104659-25-057836
- form_type: 8-K
- ticker: MRKR
- cik: 0001094038
- company_name: Marker Therapeutics, Inc.
- filed_at: 2025-06-09T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1094038/000110465925057836/0001104659-25-057836-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1094038/000110465925057836/tm2517533d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-057836
- JSON: https://secwatch.observer/filing/0001104659-25-057836.json
- Plain text: https://secwatch.observer/filing/0001104659-25-057836.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.